According to Gen Consulting Company, the global clinical trial biorepository and archiving solutions market is set to achieve an incremental growth of USD 2.0 billion, acelerating at a CAGR of almost 7.8% during the forecast period 2022-2028.

The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global clinical trial biorepository and archiving solutions market. It traces the market’s historic and forecast market growth. The report identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches. This study also provides an analysis of the impact of the COVID-19 crisis on the clinical trial biorepository and archiving solutions industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the service, product type, phase, and region. The global market for clinical trial biorepository and archiving solutions can be segmented by service: biorepository service, archiving solution service. Globally, the biorepository service segment made up the largest share of the clinical trial biorepository and archiving solutions market. Clinical trial biorepository and archiving solutions market is further segmented by product type: preclinical product, clinical product. The clinical product segment captured the largest share of the market in 2021. Based on phase, the clinical trial biorepository and archiving solutions market is segmented into: phase I, phase II, phase III, phase IV. According to the research, the phase III segment had the largest share in the global clinical trial biorepository and archiving solutions market. On the basis of region, the clinical trial biorepository and archiving solutions market also can be divided into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. North America held the largest revenue share in 2021.

Market Segmentation
By service: biorepository service, archiving solution service
By product type: preclinical product, clinical product
By phase: phase I, phase II, phase III, phase IV
By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America

The report also provides a detailed analysis of several leading clinical trial biorepository and archiving solutions market vendors that include Azenta US, Inc., Charles River Laboratories International, Inc., LabConnect, Labcorp Drug Development, Inc., Medpace Holdings, Inc., Patheon N.V., Precision For Medicine, Inc., Q2 Solutions LLC, among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report
– To analyze and forecast the market size of the global clinical trial biorepository and archiving solutions market.
– To classify and forecast the global clinical trial biorepository and archiving solutions market based on service, product type, phase, region.
– To identify drivers and challenges for the global clinical trial biorepository and archiving solutions market.
– To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global clinical trial biorepository and archiving solutions market.
– To identify and analyze the profile of leading players operating in the global clinical trial biorepository and archiving solutions market.

Why Choose This Report
– Gain a reliable outlook of the global clinical trial biorepository and archiving solutions market forecasts from 2022 to 2028 across scenarios.
– Identify growth segments for investment.
– Stay ahead of competitors through company profiles and market data.
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.